
Healthcare / Pharmaceuticals · NSE
Galaxy Medicare Limited, incorporated in July 1992, is engaged in the manufacturing and export of medical devices, POP bandages, and surgical dressings in India. The company uses premium-grade raw materials sourced from authentic vendors to ensure quality in its production. Its product portfolio includes surgical dressings, plaster of Paris bandages, adhesive tapes, compression bandages, gauze products, wound care solutions, and orthopedic items. Galaxy Medicare operates through multiple business verticals, such as manufacturing and branding under its flagship names like POP BAND, POP CAST, G CAST, GYPSOSOFT, GYPSOPLAST, CARETAPE, GYPSOCREPE, CARECREPE, CAREPORE, GYPSONET, GYPSOCHLOR, and FIXCAN, among others. It also caters to OEM requirements by sourcing, designing, manufacturing, and testing products according to brand owners’ specifications on a Principal-to-Principal basis. Additionally, the company participates in institutional sales through government tenders on the GEM portal, exports its products internationally, and trades in surgical devices and dressings. With 27 registered trademarks in India, its products are widely accepted by the medical community and supplied across the country to government health departments, corporate hospitals, and private organizations. The company holds ISO 9001:2015 and ISO 13485:2016 certifications, reflecting its commitment to quality and adherence to global standards. As of March 2025, Galaxy Medicare employs 190 people across various departments.
Price Band
₹51 – ₹54
Issue Size
₹22.31 Cr
Lot Size
2000 shares
GMP
Est. Listing
₹54
at current GMP
Subscribed
1.89x
overall
Open
10 Sep 2025
Close
12 Sep 2025
Allotment
15 Sep 2025
Refund
16 Sep 2025
Demat Credit
17 Sep 2025
Listing
17 Sep 2025
Last updated: 21 Nov 2025
Current Premium
Issue Price (Upper)
₹54
Band: ₹51 – ₹54
Estimated Listing Price
₹54
Upper price + GMP
Lot Size
2000 shares
Min investment ₹1,08,000
Estimated Profit / Lot
₹0
2000 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹54 |
| 30 Oct 2026 | — | 0.0% | ₹54 |
| 29 Oct 2026 | — | 0.0% | ₹54 |
GMP is unofficial market data. Not a guarantee of listing performance.
Galaxy Medicare Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹22.31 Crores. The shares are offered at a price band of ₹51 to ₹54 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2025-09-12, the basis of allotment is scheduled to be finalized on 2025-09-15. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Cameo Corporate Services Limited) or the BSE allotment checking window.
The latest grey market premium for Galaxy Medicare Limited IPO is ₹0, which indicates an expected listing price of ₹54.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.